A common polymorphism in methionine synthase reductase increases risk of premature coronary artery disease

Journal of Cardiovascular Risk

Volumn 7, Issue 3, 2000, Pages 197-200

  Brown, Charlotte A ^a   McKinney, Kimberly Q ^a   Kaufman, Jay S ^b   Gravel, Roy A ^c   Rozen, Rima ^c  

^a CAROLINAS MEDICAL CENTER   (United States)

^b IL   (United States)

^c MONTREAL CHILDREN S HOSPITAL   (Canada)

Author keywords

Coronary artery disease; Folate; Homocysteine; Methionine synthase reductase; Vitamin B12

Indexed keywords

COBALAMIN; CYANOCOBALAMIN; FOLIC ACID; HOMOCYSTEINE; METHIONINE SYNTHASE; OXIDOREDUCTASE;

ADULT; ARTICLE; CARDIOVASCULAR RISK; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DNA SEQUENCE; FEMALE; GENETIC POLYMORPHISM; GENOTYPE; HEART CATHETERIZATION; HUMAN; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RISK FACTOR; SPINA BIFIDA;

EID: 0033912873     PISSN: 13506277     EISSN: None     Source Type: Journal    
DOI: 10.1177/204748730000700306     Document Type: Article

References (18)

1. 1 Mudd SH, Levy HL, Skovby F. Disorder of transsulfuration. In: Scriver CR, Beaudet AL, Sly WS, Valle D (editors): The metabolic basis of inherited disease. New York: McGraw-Hill; 1995. p. 1279.
2. 2 Ueland PM, Refsum H, Brattstrom L. Plasma homocysteine and vascular disease. In: Francis RB Jr (editor): Atherosclerotic cardiovascular disease, haemostasis and endothelial function. New York: Marcel Dekker; 1992. pp. 183.
3. 3 D'Angelo A, Selhub J. Homocysteine and thrombotic disease. Blood 1997; 90:1-11.
4. 4 Boers GHJ. Hyperhomocysteinemia as a risk factor for arterial and venous disease. A review of evidence and relevance. Thromb Haemost 1997; 77:520-522.
5. 5 Boushey CJ, Beresford SAA, Omenn G, Motulsky AG. A quantitative assessment of plasma homocysteine as a risk factor for vascular disease: probable benefits of raising folic acid intakes. JAMA 1995; 274:1049-1057.
6. 6 Selhub J, Miller JW. The pathogenesis of homocysteinemia: interruption of the coordinate regulation by S-adenosylmethionine of the remethylation and transsulfuration of homocysteine. Am J Clin Nutr 1991; 55:131-138.
7. 7 Verhoef P, Stampfer MJ, Buring JE, Gaziano JM, Allen RH, Stabler SP, et al. Homocysteine metabolism and risk of myocardial infarction: relation with vitamins B6, B12 and folate. Am J Epidemiol 1996; 143:845-859.
8. 8 Folsom AR, Nieto FJ, McGovern PG, Tsai MY, Malinow MR, Eckfeldt JH, et al. Prospective study of coronary heart disease incidence in relation to fasting total homocysteine, related genetic polymorphisms and B vitamins. Circulation 1998; 98:204-210.
9. 9 Jacques PF, Bostom AG, Williams RR, Ellison RC, Eckfeldt JH, Rosenberg IH, et al. Relation between folate status, a common mutation in methylenetetrahydrofolate reductase, and plasma homocysteine concentrations. Circulation 1996; 93:7-9.
10. 10 Girelli D, Friso S, Trabetti E, Olivierei O, Russo C, Pessotto R, et al. Methylenetetrahydrofolate reductase C677T mutation, plasma homocysteine, and folate in subjects from northern Italy with or without angiographically documented severe coronary atherosclerotic disease: evidence for an important genetic-environmental interaction. Blood 1998; 91:4158-4163.
11. 11 Rosenblatt D. Inherited disorders of folate transport and metabolism. In: Scriver CR, Beaudet AL, Sly WS, Valle D (editors): The metabolic basis of inherited disease. New York: McGraw-Hill; 1995. pp. 3111-3128.
12. 12 Fenton WA, Rosenberg LE. Inherited disorders of cobalamin transport and metabolism. In: Scriver CR, Beaudet AL, Sly WS, Valle D (editors): The metabolic basis of inherited disease. New York: McGraw-Hill; 1995. pp. 3129-3149.
13. 12-dependent enzymes. Annu Rev Biochem 1997; 66:269-313.
14. 14 Leclerc D, Wilson A, Dumas R, Gafuik C, Song D, Watkins D, et al. Cloning and mapping of a cDNA for methionine synthase reductase, a flavoprotein defective in patients with homocystinuria. Proc Natl Acad Sci USA 1998; 95:3059-3064.
15. 15 Wilson A, Leclerc D, Rosenblatt DS, Gravel RA. Molecular basis for methionine synthase reductase deficiency in patients belonging to the cblE complementation group of disorders in folate/cobalamin metabolism. Human Molec Genet 1999; 8:2009-2016.
16. 12) increases risk for spina bifida. Molec Genet Metab 1999; 67:317-323.
17. 17 Cuzick JA. Wllcoxon-type test for trend. Statist Med 1985; 4:87-90.
18. 18 Wacholder S. Binomial regression in GLIM: estimating risk ratios and risk differences. Am J Epidemiol 1986; 123:174-184.